Use caution Drug recall · FDA · Published April 25, 2025

Baxter Infuvite Adult Recall: Cold Chain Breach Risk

Baxter recalls specific lots of Infuvite Adult injection due to potential cold chain breaches during transit. Check lot numbers AA2279 and AA2383.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0401-2025Drug Baxter ›

Use caution until it’s fixed

Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.

Take action

Contact the company

Recalling firmMckesson Medical-Surgical Inc. Corporate Office9954 Maryland Drive, Deep Run Iii Ste. 4000 · Richmond, VA 23233

✎ GovInfoNow plain-language explainer

Baxter Healthcare Corporation, distributed by Mckesson Medical-Surgical Inc., is recalling specific lots of Infuvite Adult, a multiple vitamins injection. The recall was initiated because severe thunderstorms caused transit delays that may have exposed the product to temperatures outside its recommended storage conditions. This exposure could impact the safety, quality, identity, potency, and purity of the medication. Read more at govinfonow.com/recall/32095-baxter-infuvite-adult-recall-cold-chain-breach-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32095-baxter-infuvite-adult-recall-cold-chain-breach-risk · Updated October 9, 2026 · FDA enforcement record: FDA #D-0401-2025

Cite this page

“Baxter Infuvite Adult Recall: Cold Chain Breach Risk.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/32095-baxter-infuvite-adult-recall-cold-chain-breach-risk. Based on FDA recall #D-0401-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0401-2025%22&limit=1).

The FDA announced on April 25, 2025, that Mckesson Medical-Surgical Inc. Corporate Office is recalling Baxter Infuvite Adult Injection due to potential storage condition failures. The recall affects 15 units distributed to medical facilities in Mississippi and Florida.

How to tell if you have it

Brand: Baxter
Product: Infuvite Adult Injection
NDC: 54643-5649-1
Lot codes: AA2279, Exp 8/31/26; AA2383, Exp 9/30/26
Quantity: 15 units

The hazard

The FDA stated that severe thunderstorms caused transit delays for products shipped on April 2, 2025, and delivered after the specified 48-hour window. The affected products may not have been stored at recommended labeled conditions, potentially impacting safety, quality, identity, potency, and purity.

Context

GovInfoNow's records show Mckesson Medical-Surgical Inc. Corporate Office has 14 other recalls on record since June 2, 2021. Other recent recalls of similar products include Clearview Strep A Exact II Dipstick Respiratory Kit Recall (July 30, 2025), BD Microbiology MacConkey II Agar Recall (April 24, 2025), and BENLYSTA 400 mg/20 mL vial recall (April 21, 2025). Other recent recalls of similar products include Baxter Vasopressin Injection Recall (August 6, 2026), Baxter Famotidine Injection Recall (August 6, 2026), and Baxter Pantoprazole Sodium Injection Recall (August 6, 2026).

How to tell if you have this one

Look for Infuvite Adult, multiple vitamins injection, manufactured by Baxter and distributed by Sandoz Inc. Check the NDC 54643-5649-1 and verify if the lot number is AA2279 (Expiration 8/31/26) or AA2383 (Expiration 9/30/26). The product comes in Five of Vial 1 (5 mL) and Five of Vial 2 (5mL) packs.

Brand
Baxter
Category
Drug

FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

Classification
Class II
Status
Ongoing
Distribution
Distributed to Medical Facilities in MS and FL.

Recall number	Product, codes & lots	Quantity	NDC
D-0400-2025	Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-0330-01; Lot #: 1MP24042, Exp 6/30/26	3	—
D-0401-2025	Infuvite Adult, multiple vitamins injection, Baxter, Five of Vial 1 (5 mL) and Five of Vial 2 (5mL), Rx Only, Sterile, Manufactured for: Sandoz Inc., Princeton, NJ 08540, Distributed by Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product of Canada, NDC 54643-5649-1; Lot #: AA2279, Exp 8/31/26; AA2383, Exp 9/30/26	15	54643-5649-1, 54643-5657-1, 54643-5659-1, 54643-5650-2, 54643-5661-2, 54643-5663-2

Based on the official FDA remedy

What to do — step by step

Identify Affected Lots
Check your inventory for Infuvite Adult injection with lot numbers AA2279 or AA2383 and NDC 54643-5649-1.
Contact Supplier
Reach out to Mckesson Medical-Surgical Inc. Corporate Office for further instructions on handling these units.

Where it went and when

Where it was distributed

Distributed in Florida and Mississippi.

FDA distribution: “Distributed to Medical Facilities in MS and FL.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Florida, Mississippi.

Recall timeline

FDA published this recall 12 days after the firm started it.

Apr 25, 2025Firm started the recall
May 1, 2025FDA classified it Class II
May 7, 2025Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/32095-baxter-infuvite-adult-recall-cold-chain-breach-risk">Baxter Infuvite Adult Recall: Cold Chain Breach Risk (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0401-2025 (April 25, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0401-2025 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.